Selected research
Industry Research
Macrolide Antibiotics Industry Research Report 2026
Market perspective
The global Macrolide Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Macrolide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Macrolide Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Macrolide Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Macrolide Antibiotics include Macrolide Pharmaceuticals, Neo Química, Fresenius Kabi, Pfizer, Merck, Sandoz International and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Macrolide Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Macrolide Antibiotics Market by Company
Macrolide Pharmaceuticals
Neo Química
Fresenius Kabi
Pfizer
Merck
Sandoz International
Teva Pharmaceutical Industries
Macrolide Antibiotics Segment by Type
Azithromycin
Fidaxomicin
Erythromycin
Clarithromycin
Telithromycin
Macrolide Antibiotics Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Macrolide Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macrolide Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Macrolide Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macrolide Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Macrolide Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Macrolide Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Macrolide Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Azithromycin
- Fidaxomicin
- Erythromycin
- Clarithromycin
- Telithromycin
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Macrolide Pharmaceuticals
- Neo Química
- Fresenius Kabi
- Pfizer
- Merck
- Sandoz International
- Teva Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Macrolide Antibiotics Market Size (2021-2032)
- 2.2.2 Global Macrolide Antibiotics Sales (2021-2032)
- 2.2.3 Global Macrolide Antibiotics Market Average Price (2021-2032)
- 2.3 Macrolide Antibiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Azithromycin
- 2.3.3 Fidaxomicin
- 2.3.4 Erythromycin
- 2.3.5 Clarithromycin
- 2.3.6 Telithromycin
- 2.4 Macrolide Antibiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Macrolide Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Macrolide Antibiotics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Macrolide Antibiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Macrolide Antibiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Macrolide Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Macrolide Antibiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Macrolide Antibiotics, Product Type & Application
- 3.8 Global Manufacturers of Macrolide Antibiotics, Established Date
- 3.9 Global Macrolide Antibiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Macrolide Pharmaceuticals
- 4.1.1 Macrolide Pharmaceuticals Company Information
- 4.1.2 Macrolide Pharmaceuticals Business Overview
- 4.1.3 Macrolide Pharmaceuticals Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Macrolide Pharmaceuticals Macrolide Antibiotics Product Portfolio
- 4.1.5 Macrolide Pharmaceuticals Recent Developments
- 4.2 Neo Química
- 4.2.1 Neo Química Company Information
- 4.2.2 Neo Química Business Overview
- 4.2.3 Neo Química Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Neo Química Macrolide Antibiotics Product Portfolio
- 4.2.5 Neo Química Recent Developments
- 4.3 Fresenius Kabi
- 4.3.1 Fresenius Kabi Company Information
- 4.3.2 Fresenius Kabi Business Overview
- 4.3.3 Fresenius Kabi Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi Macrolide Antibiotics Product Portfolio
- 4.3.5 Fresenius Kabi Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Macrolide Antibiotics Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Macrolide Antibiotics Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Sandoz International
- 4.6.1 Sandoz International Company Information
- 4.6.2 Sandoz International Business Overview
- 4.6.3 Sandoz International Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sandoz International Macrolide Antibiotics Product Portfolio
- 4.6.5 Sandoz International Recent Developments
- 4.7 Teva Pharmaceutical Industries
- 4.7.1 Teva Pharmaceutical Industries Company Information
- 4.7.2 Teva Pharmaceutical Industries Business Overview
- 4.7.3 Teva Pharmaceutical Industries Macrolide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva Pharmaceutical Industries Macrolide Antibiotics Product Portfolio
- 4.7.5 Teva Pharmaceutical Industries Recent Developments
5 Global Macrolide Antibiotics Market Scenario by Region
- 5.1 Global Macrolide Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Macrolide Antibiotics Sales by Region: 2021-2032
- 5.2.1 Global Macrolide Antibiotics Sales by Region: 2021-2026
- 5.2.2 Global Macrolide Antibiotics Sales by Region: 2027-2032
- 5.3 Global Macrolide Antibiotics Revenue by Region: 2021-2032
- 5.3.1 Global Macrolide Antibiotics Revenue by Region: 2021-2026
- 5.3.2 Global Macrolide Antibiotics Revenue by Region: 2027-2032
- 5.4 North America Macrolide Antibiotics Market Facts & Figures by Country
- 5.4.1 North America Macrolide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Macrolide Antibiotics Sales by Country (2021-2032)
- 5.4.3 North America Macrolide Antibiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Macrolide Antibiotics Market Facts & Figures by Country
- 5.5.1 Europe Macrolide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Macrolide Antibiotics Sales by Country (2021-2032)
- 5.5.3 Europe Macrolide Antibiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Macrolide Antibiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Macrolide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Macrolide Antibiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Macrolide Antibiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Macrolide Antibiotics Market Facts & Figures by Country
- 5.7.1 South America Macrolide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Macrolide Antibiotics Sales by Country (2021-2032)
- 5.7.3 South America Macrolide Antibiotics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Macrolide Antibiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Macrolide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Macrolide Antibiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Macrolide Antibiotics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Macrolide Antibiotics Sales by Type (2021-2032)
- 6.1.1 Global Macrolide Antibiotics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Macrolide Antibiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Macrolide Antibiotics Revenue by Type (2021-2032)
- 6.2.1 Global Macrolide Antibiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Macrolide Antibiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Macrolide Antibiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Macrolide Antibiotics Sales by Application (2021-2032)
- 7.1.1 Global Macrolide Antibiotics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Macrolide Antibiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Macrolide Antibiotics Revenue by Application (2021-2032)
- 7.2.1 Global Macrolide Antibiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Macrolide Antibiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Macrolide Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Macrolide Antibiotics Value Chain Analysis
- 8.1.1 Macrolide Antibiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Macrolide Antibiotics Production Mode & Process
- 8.2 Macrolide Antibiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Macrolide Antibiotics Distributors
- 8.2.3 Macrolide Antibiotics Customers
9 Global Macrolide Antibiotics Analyzing Market Dynamics
- 9.1 Macrolide Antibiotics Industry Trends
- 9.2 Macrolide Antibiotics Industry Drivers
- 9.3 Macrolide Antibiotics Industry Opportunities and Challenges
- 9.4 Macrolide Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst